vs
CALERES INC（CAL）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是CALERES INC的1.8倍（$1.4B vs $790.1M），瑞思迈净利率更高（27.6% vs 0.3%，领先27.3%），瑞思迈同比增速更快（11.0% vs 6.6%），瑞思迈自由现金流更多（$311.2M vs $-12.4M），过去两年瑞思迈的营收复合增速更高（9.0% vs 6.5%）
Caleres Inc是一家美国鞋履企业，旗下拥有并运营多个鞋履品牌，总部坐落于圣路易斯郊区密苏里州克莱顿。该企业前身是1878年在圣路易斯成立的Bryan, Brown & Company，此后历经多次更名，其前身汉密尔顿-布朗鞋业在20世纪初曾是美国最大的鞋履制造商。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CAL vs RMD — 直观对比
营收规模更大
RMD
是对方的1.8倍
$790.1M
营收增速更快
RMD
高出4.3%
6.6%
净利率更高
RMD
高出27.3%
0.3%
自由现金流更多
RMD
多$323.6M
$-12.4M
两年增速更快
RMD
近两年复合增速
6.5%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $790.1M | $1.4B |
| 净利润 | $2.4M | $392.6M |
| 毛利率 | 41.8% | 61.8% |
| 营业利润率 | 1.5% | 34.6% |
| 净利率 | 0.3% | 27.6% |
| 营收同比 | 6.6% | 11.0% |
| 净利润同比 | -94.2% | 13.9% |
| 每股收益（稀释后） | $0.07 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CALRMD
| Q4 25 | $790.1M | $1.4B | ||
| Q3 25 | $658.5M | $1.3B | ||
| Q2 25 | $614.2M | $1.3B | ||
| Q1 25 | $639.2M | $1.3B | ||
| Q4 24 | $740.9M | $1.3B | ||
| Q3 24 | $683.3M | $1.2B | ||
| Q2 24 | $659.2M | $1.2B | ||
| Q1 24 | $697.1M | $1.2B |
净利润CALRMD
| Q4 25 | $2.4M | $392.6M | ||
| Q3 25 | $6.7M | $348.5M | ||
| Q2 25 | $6.9M | $379.7M | ||
| Q1 25 | $4.9M | $365.0M | ||
| Q4 24 | $41.4M | $344.6M | ||
| Q3 24 | $30.0M | $311.4M | ||
| Q2 24 | $30.9M | $292.2M | ||
| Q1 24 | $55.7M | $300.5M |
毛利率CALRMD
| Q4 25 | 41.8% | 61.8% | ||
| Q3 25 | 43.4% | 61.5% | ||
| Q2 25 | 45.4% | 60.8% | ||
| Q1 25 | 43.0% | 59.3% | ||
| Q4 24 | 44.1% | 58.6% | ||
| Q3 24 | 45.5% | 58.6% | ||
| Q2 24 | 46.9% | 58.5% | ||
| Q1 24 | 43.9% | 57.9% |
营业利润率CALRMD
| Q4 25 | 1.5% | 34.6% | ||
| Q3 25 | 1.4% | 33.4% | ||
| Q2 25 | 1.9% | 33.7% | ||
| Q1 25 | 1.2% | 33.0% | ||
| Q4 24 | 7.7% | 32.5% | ||
| Q3 24 | 6.2% | 31.6% | ||
| Q2 24 | 6.5% | 31.2% | ||
| Q1 24 | 4.4% | 31.3% |
净利率CALRMD
| Q4 25 | 0.3% | 27.6% | ||
| Q3 25 | 1.0% | 26.1% | ||
| Q2 25 | 1.1% | 28.2% | ||
| Q1 25 | 0.8% | 28.3% | ||
| Q4 24 | 5.6% | 26.9% | ||
| Q3 24 | 4.4% | 25.4% | ||
| Q2 24 | 4.7% | 23.9% | ||
| Q1 24 | 8.0% | 25.1% |
每股收益（稀释后）CALRMD
| Q4 25 | $0.07 | $2.68 | ||
| Q3 25 | $0.20 | $2.37 | ||
| Q2 25 | $0.21 | $2.58 | ||
| Q1 25 | $0.17 | $2.48 | ||
| Q4 24 | $1.19 | $2.34 | ||
| Q3 24 | $0.85 | $2.11 | ||
| Q2 24 | $0.88 | $1.97 | ||
| Q1 24 | $1.56 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $616.8M | $6.3B |
| 总资产 | $2.1B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CALRMD
| Q4 25 | $34.0M | $1.4B | ||
| Q3 25 | $191.5M | $1.4B | ||
| Q2 25 | $33.1M | $1.2B | ||
| Q1 25 | $29.6M | $932.7M | ||
| Q4 24 | $33.7M | $521.9M | ||
| Q3 24 | $51.8M | $426.4M | ||
| Q2 24 | $30.7M | $238.4M | ||
| Q1 24 | $21.4M | $237.9M |
总债务CALRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益CALRMD
| Q4 25 | $616.8M | $6.3B | ||
| Q3 25 | $613.3M | $6.1B | ||
| Q2 25 | $605.2M | $6.0B | ||
| Q1 25 | $599.0M | $5.5B | ||
| Q4 24 | $598.3M | $5.3B | ||
| Q3 24 | $606.1M | $5.2B | ||
| Q2 24 | $570.3M | $4.9B | ||
| Q1 24 | $560.6M | $4.6B |
总资产CALRMD
| Q4 25 | $2.1B | $8.5B | ||
| Q3 25 | $2.2B | $8.3B | ||
| Q2 25 | $1.9B | $8.2B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $2.0B | $7.1B | ||
| Q3 24 | $2.0B | $7.2B | ||
| Q2 24 | $1.9B | $6.9B | ||
| Q1 24 | $1.8B | $6.8B |
负债/权益比CALRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.4M | $311.2M |
| 自由现金流率自由现金流/营收 | -1.6% | 21.9% |
| 资本支出强度资本支出/营收 | 1.4% | 2.0% |
| 现金转化率经营现金流/净利润 | -0.50× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $14.4M | $1.8B |
8季度趋势，按日历期对齐
经营现金流CALRMD
| Q4 25 | $-1.2M | $339.7M | ||
| Q3 25 | $47.3M | $457.3M | ||
| Q2 25 | $-5.7M | $538.8M | ||
| Q1 25 | $28.7M | $578.7M | ||
| Q4 24 | $-39.8M | $308.6M | ||
| Q3 24 | $79.6M | $325.5M | ||
| Q2 24 | $36.1M | $440.1M | ||
| Q1 24 | $43.0M | $402.0M |
自由现金流CALRMD
| Q4 25 | $-12.4M | $311.2M | ||
| Q3 25 | $35.0M | $414.4M | ||
| Q2 25 | $-26.2M | $508.2M | ||
| Q1 25 | $18.0M | $557.9M | ||
| Q4 24 | $-57.4M | $288.0M | ||
| Q3 24 | $68.5M | $307.7M | ||
| Q2 24 | $26.3M | $415.2M | ||
| Q1 24 | $32.4M | $380.8M |
自由现金流率CALRMD
| Q4 25 | -1.6% | 21.9% | ||
| Q3 25 | 5.3% | 31.0% | ||
| Q2 25 | -4.3% | 37.7% | ||
| Q1 25 | 2.8% | 43.2% | ||
| Q4 24 | -7.7% | 22.5% | ||
| Q3 24 | 10.0% | 25.1% | ||
| Q2 24 | 4.0% | 33.9% | ||
| Q1 24 | 4.6% | 31.8% |
资本支出强度CALRMD
| Q4 25 | 1.4% | 2.0% | ||
| Q3 25 | 1.9% | 3.2% | ||
| Q2 25 | 3.3% | 2.3% | ||
| Q1 25 | 1.7% | 1.6% | ||
| Q4 24 | 2.4% | 1.6% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 1.5% | 2.0% | ||
| Q1 24 | 1.5% | 1.8% |
现金转化率CALRMD
| Q4 25 | -0.50× | 0.87× | ||
| Q3 25 | 7.05× | 1.31× | ||
| Q2 25 | -0.81× | 1.42× | ||
| Q1 25 | 5.82× | 1.59× | ||
| Q4 24 | -0.96× | 0.90× | ||
| Q3 24 | 2.66× | 1.05× | ||
| Q2 24 | 1.17× | 1.51× | ||
| Q1 24 | 0.77× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
